Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1042 dni temu
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 786 dni temu
Wall Street May Open With Slightly Negative Bias

Wall Street May Open With Slightly Negative Bias

Slightly lower S&P and Nasdaq futures amid valuation concerns indicate a flat to negative start for stocks on Wall Street Wednesday morning. Data on manufacturing and services sector activity in the U.S. in the month of October may provide some direction to the mark
RTTNews | 2g 0 minut temu
FTSE 100 Recovers After Weak Start, Up Marginally At Noon

FTSE 100 Recovers After Weak Start, Up Marginally At Noon

The U.K. stock market's benchmark index FTSE 100 was up marginally around noon on Wednesday with investors largely choosing to stay away from riskier assets due to concerns about valuations amid lingering uncertainty about global economic growth.
RTTNews | 2g 42 minut temu
Eurozone Private Sector Expands Most Since Early 2023

Eurozone Private Sector Expands Most Since Early 2023

The euro area private sector posted its strongest expansion since May 2023, supported by improved demand conditions, final survey data from S&P Global showed on Wednesday. The HCOB final composite output index improved to 52.5 in October from 51.2 in September. This was the highest score since May 2023, indicating a breakout from the generally subdued growth trend seen throughout 2025 so far.
RTTNews | 2g 54 minut temu